← Open Payments lookup

NICOLE MIXAN: Open Payments

NPI 1841758372 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,215 in 57 payments from 18 companies in 2025. Trend: 2023 $1,309 · 2024 $2,264 · 2025 $1,215

Food & beverage: $1,215
CompanyPaymentsAmount
ABBVIE INC.20$318
Novo Nordisk Inc6$221
Bayer Healthcare Pharmaceuticals Inc.3$152
PFIZER INC.5$82
Lilly USA, LLC4$78
AstraZeneca Pharmaceuticals LP3$59
Aimmune Therapeutics, Inc.2$48
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$48
Neuronetics, Inc.1$41
Exact Sciences Corporation2$29

Products named: Kerendia, VRAYLAR, CREON, QULIPTA, MOUNJARO, PREVNAR 20, UBRELVY, ZENPEP.

Industry payments across NE — which companies pay providers there.